You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed metastatic melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low

Recruiting
  • NSCLC
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 28, 2022

Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)

Recruiting
  • Melanoma
  • +2 more
  • LYL845
  • Columbus, Ohio
  • +3 more
Dec 19, 2022

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Tumor, Metastatic Melanoma, Melanoma Trial in Houston (OBX-115, Acetazolamide, Cyclophosphamide)

Not yet recruiting
  • Tumor
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 16, 2022

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

Recruiting
  • Astrocytoma
  • +22 more
  • Kogarah, New South Wales, Australia
  • +1 more
Apr 18, 2022

Melanoma Trial in Fairway (tvs-CTL Vaccine)

Completed
  • Melanoma
  • tvs-CTL Vaccine
  • Fairway, Kansas
    KU Cancer Center
Jan 20, 2022

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Immunotherapy in Patients With Metastatic Melanoma

Not yet recruiting
  • Metastatic Melanoma
  • data collection
  • (no location specified)
Nov 28, 2022

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)

    Recruiting
    • Melanoma (Skin)
    • Melanoma, Uveal
    • Oxford, United Kingdom
      Churchill Hospital, Oxford University Hospitals NHS Trust
    Jul 28, 2022

    Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

    Not yet recruiting
    • Metastatic Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 19, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 28, 2023

    Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

    Recruiting
    • Uveal Melanoma
    • Supportive care visit with questionnaires
    • Oncological standard visit
    • Nice, France
    • +1 more
    Jan 19, 2023

    Baseline Metastases on Clinical Outcomes Among BRAF Positive

    Completed
    • BRAF Positive Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis
      Aug 2, 2023

      Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

      Active, not recruiting
      • Melanoma
      • Beijing City, China
      • +2 more
      Dec 13, 2022

      Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

      Not yet recruiting
      • Advanced Melanoma
      • Metastatic Melanoma
      • Memory-like natural killer cells
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 16, 2022

      Associated Factors, and Clinical Outcomes of Prescribing

      Completed
      • BRAF v600 Mutated Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Mar 28, 2023

        Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

        Recruiting
        • Metastatic Melanoma
        • BRAF Gene Mutation
        • Nilotinib 100mg
        • +5 more
        • Lexington, Kentucky
          Markey Cancer Center
        Jul 22, 2022